tradingkey.logo
tradingkey.logo
Search

Mangoceuticals Inc

MGRX
Add to Watchlist
0.557USD
+0.263+89.58%
Close 07-31 16:00ETQuotes delayed by 15 min
7.73MMarket Cap
LossP/E TTM

MGRX Financials

See Mangoceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Mangoceuticals Inc Earnings Date

Latest Release
May 19, 2026
EPS / Forecast
-0.21/--
Revenue / Forecast
67.86K/--
Period
FY2025 Earnings
Revenue(YoY)
456.02K
-25.96%
EPS(YoY)
-2.17
50.76%
Analyst Rating
--
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
Financial Indicators
EPS
80.40%-0.21
70.96%-0.22
95.38%-0.69
60.52%-0.54
32.26%-1.05
62.02%-0.74
-776.03%-14.85
36.74%-1.37
54.41%-1.56
-235.34%-1.96
---1.70
---2.17
---3.41
---0.58
---1.15
----
Revenue
-37.91%67.86K
-10.34%94.36K
-36.83%84.25K
3.03%168.11K
-48.95%109.31K
-56.93%105.25K
-45.60%133.37K
15.52%163.16K
112.56%214.09K
2633.80%244.37K
--245.16K
--141.24K
--100.72K
--8.94K
--0.00
----
Net Profit
29.68%-3.40M
-57.24%-3.06M
-295.76%-7.91M
-126.51%-5.42M
-104.40%-4.84M
24.13%-1.95M
-11.10%-2.00M
-4.68%-2.39M
7.55%-2.37M
-281.21%-2.57M
-80.87%-1.80M
---2.28M
---2.56M
---673.65K
---994.91K
----
Net Margin
-13.26%-5014.65%
-58.52%-2934.90%
-503.15%-9043.49%
-119.82%-3221.61%
-300.36%-4427.47%
-76.18%-1851.45%
-104.28%-1499.38%
9.37%-1465.60%
56.51%-1105.87%
86.06%-1050.87%
---733.99%
---1617.16%
---2542.53%
---7536.13%
----
----
Gross Margin
-743.12%-365.16%
-86.96%-1139.43%
-2.53%60.42%
25.09%53.51%
-17.53%56.78%
-1144.54%-609.45%
5.10%61.99%
-30.66%42.77%
21.23%68.85%
7.54%58.35%
--58.98%
--61.69%
--56.79%
--54.26%
----
----
Debt to assets ratio
----
-100.00%0.00%
-52.28%0.60%
133.95%2.88%
-100.00%0.00%
--0.98%
--1.27%
--1.23%
1239.16%29.03%
-100.00%0.00%
--0.00%
--0.00%
--2.17%
--16.69%
--9.76%
----
Revenue
-37.91%67.86K
-10.34%94.36K
-36.83%84.25K
3.03%168.11K
-48.95%109.31K
-56.93%105.25K
-45.60%133.37K
15.52%163.16K
112.56%214.09K
2633.80%244.37K
--245.16K
--141.24K
--100.72K
--8.94K
--0.00
----
Operating profit
29.88%-3.40M
37.88%-1.49M
-329.04%-7.54M
-142.94%-5.27M
-104.98%-4.85M
6.58%-2.40M
2.30%-1.76M
5.39%-2.17M
7.48%-2.37M
-282.23%-2.57M
-81.43%-1.80M
---2.29M
---2.56M
---671.86K
---991.83K
----
Net Profit
29.68%-3.40M
-57.24%-3.06M
-295.76%-7.91M
-126.51%-5.42M
-104.40%-4.84M
24.13%-1.95M
-11.10%-2.00M
-4.68%-2.39M
7.55%-2.37M
-281.21%-2.57M
-80.87%-1.80M
---2.28M
---2.56M
---673.65K
---994.91K
----
Current assets
20.28%212.47K
1947.01%1.55M
474.84%598.22K
-77.21%117.96K
96.70%176.65K
-90.76%75.59K
-92.25%104.07K
-82.88%517.56K
-97.65%89.81K
17.83%818.46K
50.15%1.34M
348258.18%3.02M
--3.82M
--694.61K
--894.27K
--868.00
Total current liabilities
-50.93%737.61K
-37.52%890.57K
-42.20%804.27K
16.16%1.60M
24.01%1.50M
575.33%1.43M
774.12%1.39M
601.47%1.38M
562.98%1.21M
-19.00%211.08K
77.12%159.18K
41.15%196.48K
--182.84K
--260.58K
--89.87K
--139.20K
Total assets
-33.58%14.45M
4.68%16.09M
11.76%16.53M
36.78%20.84M
7116.48%21.75M
1362.75%15.37M
827.11%14.79M
362.23%15.24M
-92.67%301.45K
4.74%1.05M
74.61%1.60M
379688.25%3.30M
--4.12M
--1.00M
--913.74K
--868.00
Total liabilities
-35.17%974.57K
-37.52%890.57K
-42.70%804.27K
13.67%1.60M
19.31%1.50M
416.40%1.43M
483.15%1.40M
379.25%1.41M
325.49%1.26M
-29.09%276.04K
167.81%240.68K
111.12%293.87K
--296.11K
--389.26K
--89.87K
--139.20K
Total equity
-33.46%13.47M
8.99%15.20M
17.47%15.73M
39.14%19.24M
2212.82%20.25M
1699.93%13.95M
888.21%13.39M
360.57%13.83M
-125.10%-958.47K
26.18%774.75K
64.45%1.35M
2270.64%3.00M
--3.82M
--614.03K
--823.87K
---138.33K
Net operating income
42.35%-1.31M
4.59%-1.08M
-6.47%-1.24M
20.34%-1.26M
-129.51%-2.27M
33.47%-1.13M
31.85%-1.17M
11.34%-1.58M
45.24%-991.13K
-161.37%-1.70M
-184.96%-1.71M
---1.78M
---1.81M
---649.56K
---600.35K
----
Net investment
----
----
----
----
----
--0.00
--0.00
--65.00K
100.00%0.00
100.00%0.00
100.00%0.00
--0.00
---3.52K
---40.57K
---2.53K
----
Net financing
-100.00%0.00
85.61%2.08M
116.21%1.62M
-35.58%1.28M
754.21%2.29M
-6.46%1.12M
--750.00K
112.58%1.99M
-94.56%267.50K
140.24%1.20M
-100.00%0.00
--935.30K
--4.92M
--499.50K
--1.48M
----

FAQs

What is the total revenue of Mangoceuticals Inc?

According to Mangoceuticals Inc's FY2025 earnings report, its total revenue reached 456.02K, with a year-on-year change of 615.87K.

What are the current assets of Mangoceuticals Inc?

According to Mangoceuticals Inc's FY2025 earnings report, its current assets were 1.55M, with a year-on-year change of 1947.01.

What are the total assets of Mangoceuticals Inc?

According to Mangoceuticals Inc's FY2025 earnings report, its total assets of Mangoceuticals Inc were 16.09M, with a year-on-year change of 4.68.

What are the total liabilities of Mangoceuticals Inc?

According to Mangoceuticals Inc's FY2025 earnings report, its total liabilities of Mangoceuticals Inc were 890.57K, with a year-on-year change of -37.52.

What is the total equity of Mangoceuticals Inc?

According to Mangoceuticals Inc's FY2025 earnings report, its total equity of Mangoceuticals Inc was 15.20M, with a year-on-year change of 8.99.

What is the net operating income of Mangoceuticals Inc?

According to Mangoceuticals Inc's FY2025 earnings report, its net operating income of Mangoceuticals Inc was -19.15M, with a year-on-year change of -120.34.

What is the net financing of Mangoceuticals Inc?

According to Mangoceuticals Inc's FY2025 earnings report, its net financing of Mangoceuticals Inc was 7.27M, with a year-on-year change of 76.12.

What is the Earnings Per Share (EPS) of Mangoceuticals Inc?

According to Mangoceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.17, with a year-on-year change of 50.76.

What is the net income of Mangoceuticals Inc?

According to Mangoceuticals Inc's FY2025 earnings report, its net income was -21.82M, with a year-on-year change of -150.62.

What is the net margin of Mangoceuticals Inc?

According to Mangoceuticals Inc's FY2025 earnings report, its net profit margin was -4526.86, with a year-on-year change of -220.19.

What is the gross margin of Mangoceuticals Inc?

According to Mangoceuticals Inc's FY2025 earnings report, its gross margin was -191.27, with a year-on-year change of -244.88.

What is the Return on Equity (ROE) of Mangoceuticals Inc?

According to Mangoceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -149.72, with a year-on-year change of -26.58.

What is the Return on Assets (ROA) of Mangoceuticals Inc?

According to Mangoceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -131.24, with a year-on-year change of -23.75.

What is the operating profit of Mangoceuticals Inc?

According to Mangoceuticals Inc's FY2025 earnings report, its operating profit was -19.15M, with a year-on-year change of -120.34.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.